News | Radiation Therapy | April 26, 2017

Nine New Disease Sites Added to the NCCN Radiation Therapy Compendium

Compendium provides a single access point for radiation therapy recommendations within 33 NCCN Guidelines

Nine New Disease Sites Added to the NCCN Radiation Therapy Compendium

April 26, 2017 — The National Comprehensive Cancer Network (NCCN) continues to build its NCCN Radiation Therapy Compendium with the publication of radiation therapy (RT) recommendations from an additional nine NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines):

The new guidelines include recommendations for:

  • Acute Lymphoblastic Leukemia, Version 2.2016;
  • Basal Cell Skin Cancer, Version 1.2017;
  • Dermatofibrosarcoma Protuberans, Version 1.2017;
  • Gastric Cancer, Version 1.2017;
  • Hodgkin Lymphoma, Version 1.2017;
  • Merkel Cell Carcinoma, Version 1.2017;
  • Ovarian Cancer, Version 1.2017;
  • Squamous Cell Skin Cancer, Version 1.2017; and
  • Thymomas and Thymic Carcinomas, Version 1.2017.

Launched in March 2017, the NCCN Radiation Therapy Compendium now includes recommendations from 33 NCCN Guidelines. Additional cancer types will be published on a rolling basis over the coming months.

The compendium provides guidance on all RT modalities recommended within the NCCN Guidelines, including:

  • Intensity modulated radiation therapy (IMRT);
  • Intra-operative radiation therapy (IORT);
  • Stereotactic radiosurgery (SRS)/stereotactic body radiotherapy (SBRT)/stereotactic ablative radiotherapy (SABR);
  • Image-guided radiotherapy (IGRT);
  • Low dose-rate brachytherapy (LDR)/High dose-rate brachytherapy (HDR);
  • Radioisotope; and
  • Particle therapy.

Transparency of NCCN Guidelines and Compendia development is central to the philosophy, policies and procedures of NCCN. NCCN posts the policies and processes for developing and maintaining the NCCN Guidelines. These policies are available to the public on the NCCN website. Identification of newly published research, NCCN Member Institution review, external stakeholder submissions and panel review occur on an ongoing basis with at least annual review performed for NCCN Guidelines for each disease.

For more information: www.nccn.org

Related Content

RayStation Replacing Existing Treatment Planning System at Leeds Cancer Centre
News | Treatment Planning | September 24, 2018
RaySearch recently strengthened its position in the U.K. market with a major order for the treatment planning system...
Turkish Hospital Begins MR-Guided Radiation Therapy With Viewray MRIdian Linac
News | Image Guided Radiation Therapy (IGRT) | September 21, 2018
ViewRay Inc. announced that Acibadem Maslak Hospital in Istanbul, Turkey has begun treating patients with ViewRay's...
Amar Kishan, M.D.

Amar Kishan, M.D.

News | Prostate Cancer | September 11, 2018
UCLA researchers have discovered that a combination of high doses of...
Videos | Radiation Therapy | September 07, 2018
A discussion with Ehsan Samei, Ph.D., DABR, FAAPM, FSPIE, director of the Duke University Clinical Imaging Physics Gr
Boston Scientific to Acquire Augmenix Inc.
News | Patient Positioning Radiation Therapy | September 07, 2018
Boston Scientific has entered into a definitive agreement to acquire Augmenix Inc., a privately-held company which has...
Non-Canonical Strategy May Improve Cancer Radiotherapy
News | Radiation Therapy | August 29, 2018
August 29, 2018 — Although the success or failure of...
Videos | Treatment Planning | August 28, 2018
A discussion with...
Sponsored Content | Webinar | Radiation Therapy | August 28, 2018
Respiratory tumor motion often complicates the delivery of precision radiation treatment.
Tsuyama Chuo Proton Beam Center Treats First Patients With RayStation
News | Treatment Planning | August 27, 2018
Tsuyama Chuo Hospital in Okayama Prefecture, southwest Japan, has commenced clinical use of RayStation to plan pencil...
Radiation Therapy Affects Event Recall for Children With Brain Tumors
News | Radiation Therapy | August 24, 2018
Children with certain types of brain tumors who undergo radiation treatment are less likely to recall the specifics of...